Skip to main content
SpringerLink
Log in

Antineoplastic drugs

Lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lai YH, et al. Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. Medicine 101: No. 39, 2022. Available from: URL: http://doi.org/10.1097/MD.0000000000030719

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastic drugs. Reactions Weekly 1942, 33 (2023). https://doi.org/10.1007/s40278-023-32642-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32642-4

Search

Navigation